Synopsis: In a recently issued final written decision, the Patent Trial and Appeal Board (the “Board”) found all challenged ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, extends its sincere ...

Your challenge this week? Take a hike! Whether it’s a rugged mountain trail, a peaceful local forest path, or even a city ...

Equities researchers at HC Wainwright issued their FY2029 EPS estimates for Atossa Therapeutics in a research note issued to investors on Thursday, January 30th. HC Wainwright analyst E. Bodnar ...